Top Markets
Coin of the day
IR Biosciences Holdings Inc. IR Biosciences Holdings Inc.

IR Biosciences Holdings Inc.

IRBS
Classement en actions #40519
IR BioSciences Holdings, Inc. is a U.S.-based, early-stage biotechnology firm.... IR BioSciences Holdings, Inc. is a U.S.-based, early-stage biotechnology firm. Through its subsidiary, ImmuneRegen BioSciences, Inc., it concentrates on researching and developing therapies for significant health challenges, including pulmonary fibrosis, influenza infections, and neutropenia caused by radiation. The company is also actively developing Homspera and its derivatives, Radilex and Viprovex. These compounds are designed to stimulate human stem cells, enhance immune system responses, offer anti-infective properties, serve as vaccine adjuvants, and promote wound healing. Founded in 1999, IR BioSciences Holdings, Inc. maintains its headquarters in Scottsdale, Arizona.
Prix de l'action
$0.00006
Dernière synchronisation: 2025-07-15
Capitalisation boursière
$128.12K
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange IR Biosciences Holdings Inc. (IRBS)

Catégorie

Historique du rendement du dividende pour IR Biosciences Holdings Inc. (IRBS)
Le rendement du dividende (TTM) de IR Biosciences Holdings Inc. (symbole boursier : IRBS) au 2026 est : 0
Rendement moyen du dividende sur les 5 dernières années : 0.00%
Historique du rendement du dividende de IR Biosciences Holdings Inc. (IRBS) de 2026 à 2026
Rendement du dividende à la fin de chaque année (TTM)
Année Rendement du dividende Changez
Pas assez de données pour les dates fournies.
Rendements du dividende (TTM) pour des entreprises similaires ou concurrentes
Entreprise Rendement du dividende Pays
0.00%
US
0.00%
NL
0.00%
CH
0.00%
KR
0.65%
BE